Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Your monthly program includes: Once-weekly subcutaneous self-injection Reduces appetite and slows gastric emptying Supports blood sugar regulation and fat metabolism Protocol managed by Jayson Watabe, PA-C No lab draw required
Phase 2 data in patients with type 2 diabetes demonstrated HbA1c reductions of up to 2.16% at the 12mg dose after 36 weeks, along with 16.9% body weight reduction
The FDA evaluates whether the patient has a serious or life-threatening disease, whether the potential benefits outweigh the risks, and whether providing the investigational therapy will interfere with its clinical development, Turbeville said
It is possible that serious reactions which will require immediate medical attention may occur
Tuttle, H
Start tirzepatide on your next scheduled injection day
